secondary-sale-negotiation-coach

by charlie-morrison

Install this Skill

curl -fsSL -o secondary-sale-negotiation-coach.zip https://skill.seembox.com/api/v1/skills/secondary-sale-negotiation-coach/download && unzip secondary-sale-negotiation-coach.zip

Download secondary-sale-negotiation-coach.zip

SKILL.md About

---
name: secondary-sale-negotiation-coach
description: Coach a startup founder or early employee through a secondary sale — selling existing common or preferred stock to a new investor, existing investor, the company itself (buyback), or a tender vehicle, while the company stays private. Covers when secondary actually makes sense (de-risk personal, not exit), eligibility (vesting, holding period, ROFR, transfer restrictions, 83(b), QSBS holding clock), price discovery (relation to last preferred round, common-vs-preferred discount, 409A reality, bid-ask realism), structures (one-off transfer, broker-led tender, company-coordinated tender, forward contract), board / investor approval mechanics (ROFR waiver, drag-along, co-sale rights, transfer-restriction waivers), tax planning (LTCG vs STCG, QSBS 1202 exclusion, AMT on ISO exercise+sale, state-of-residence implications), what investors will and will not pay (last-round flat, slight discount, slight premium, growth-stage premium), red-flag signals from buyers (cap-stack quirks, side-letter requests, weird carve-outs), and the founder-relationship math (signaling, optics, board-trust impact). Use when founder/exec says "thinking about taking some chips off the table", "secondary tender", "selling some shares", "existing investor wants to buy more from me", "EquityZen", "Forge", "secondary market", "pre-IPO liquidity", "company buyback", "share repurchase". Triggers on phrases like "secondary sale", "secondary tender", "tender offer private company", "ROFR right of first refusal", "co-sale right", "drag-along", "common stock secondary", "preferred secondary", "QSBS Section 1202", "83(b) holding period", "founder secondary", "early employee secondary", "EquityZen", "Forge Global", "Carta X", "Hiive", "NPM Nasdaq Private Market", "company-led tender", "buyback".
---

# secondary-sale-negotiation-coach

Coach a founder, early employee, or angel investor through a secondary sale of private company stock — selling existing equity while the company stays private. Most first-time secondaries leave 20-40% of value on the table because the seller doesn't understand price discovery, structure leverage, or the founder-board relationship math.

This is not exit prep (use saas-acquisition-prep-coach for that). This is partial liquidity while staying in.

## When to engage

Trigger when the seller mentions:
- Direct: "secondary sale", "selling shares", "taking chips off the table", "partial liquidity"
- Vehicle: tender offer, company tender, broker-led, EquityZen, Forge Global, Hiive, Carta X, NPM, Caplight, Linqto, AngelList secondary, Setter Capital
- Structure: forward contract, swap, prepaid forward, share-pledge loan against shares
- Approvals: ROFR, right of first refusal, co-sale, drag-along, transfer restriction, board approval, company approval
- Tax: QSBS, Section 1202, 1244 stock, 83(b), AMT, ISO disqualifying disposition, NSO, RSU
- Buyers: existing VC investor wants to buy more, growth-stage fund offering, sovereign wealth offering, family office offering
- Company side: company-led buyback, share repurchase program, employee tender window
- Concerns: signaling to board, optics with co-founders, what other employees will think, founder-trust impact

Do not engage for: full company sale (saas-acquisition-prep-coach), IPO secondary (different mechanics — lockup + S-1 + market price), private-to-private acquisition where you're the target (different — buyer-side dynamics dominate).

## Diagnostic sweep

1. **Stage of company and round history.**
   - Last priced round (Series, valuation, date, lead investor)
   - Was it up-round, flat, down? At what multiple?
   - Cash on balance sheet, runway
   - Growth durability (last 24 months ARR/revenue + retention)
   - Forward expectation: next round in 6 / 12 / 24+ months? IPO path?

2. **Seller's position.**
   - Role: founder, CXO, early employee, angel, ex-employee
   - Fully vested? Partially? Acceleration on departure?
   - Stock type: common, options (exercised? vs unexercised?), RSUs (settled? vs unsettled?), preferred (Series Seed / A / B...)
   - Number of shares, cost basis per share
   - 83(b) filed (for restricted stock) — yes / no / unsure
   - Holding period: when did the holding clock start? Crucial for QSBS and LTCG.
   - Total stake as % of fully-diluted

3. **Why now.**
   - Life event: house, divorce, medical, kids' tuition
   - De-risk: company concentration too high
   - Diversification: comfort threshold reached
   - Tactical: tax-rate window, expected dilutive round coming, 409A about to reset
   - Departure: leaving the company, post-termination exercise window closing
   - Be honest with the seller — sometimes "I want a Tesla" is the real reason. That's fine, but inform structure choices.

4. **How much do they want to sell.**
   - Target dollar amount (gross, pre-tax)
   - Backed-into share count at expected price
   - Maximum the company will allow (typical: 10-20% of holdings during structured tender, sometimes higher for founders)
   - Minimum that's worth doing (transaction costs eat small sales)

5. **Cap-table constraints.**
   - Right of first refusal (ROFR): company first, then investors. Standard.
   - Co-sale rights: investors can sell pro-rata alongside the seller. Standard for founders.
   - Drag-along: doesn't apply to secondary, only to control sales — but check.
   - Transfer restrictions: most certificates require board approval. Read the actual stockholders' agreement.
   - Lock-ups from prior tender / IPO prep
   - Founder-specific transfer restrictions (often 6-12 month "no transfer without board" windows after major rounds)

6. **Buyer landscape.**
   - Existing investor offering to buy more (cleanest path, often best price)
   - New growth-stage fund (often building up to lead next round)
   - Secondary-specialist fund (Industry Ventures, StepStone, Greenspring, HarbourVest)
   - Tender broker / platform (EquityZen, Forge, Hiive)
   - Family office / HNWI (often via wealth manager network)
   - Sovereign wealth (PIF, Mubadala, GIC) — typically only at $1B+ valuations
   - Company itself (buyback)

## Price discovery

Common secondary price typically sits 10-30% below the last preferred round on a pre-money basis, but that benchmark is mushy. Use multiple anchors.

### Anchors to triangulate

- **Last preferred-round price.** The reference. But preferred has liquidation preference, anti-dilution protection, board rights, etc. Common stock is structurally inferior. Discount: 15-25% standard, more if preferred stack is heavy.
- **409A valuation.** Required for option pricing. Typically lags the last round by 25-35%, with strong "marketability discount." Don't sell at 409A — that's a floor, not a market price. But understand 409A: if seller's strike was set at 409A and 409A < secondary price, they're sitting on built-in spread.
- **Recent secondary trades.** If platform-listed (Forge, EquityZen) check actual cleared prices. If existing investor has bought secondary recently, ask what they paid. Beware "indications of interest" — bid-ask is wide.
- **Forward expectation.** If a Series C is forming at 2x last round in 90 days, secondary today often clears at last-round flat or with minor discount. If the next round is uncertain or rumored down, secondary trades at deep discount or doesn't clear at all.
- **Tender benchmark.** If the company has run a tender in the last 18 months, the tender price is the gravity well. Hard to clear above unless growth has accelerated dramatically.
- **Growth multiple math.** ARR / revenue × peer multiple, then × 0.7-0.85 marketability discount for private. Sanity check, not a price-setter.

### What buyers actually pay

- **Strategic existing investor:** last-round flat to +10% if writing a real check (and signaling next-round commitment). Often the best clear.
- **New growth fund building toward a lead:** discount to last round, willing to pay up if they're testing the waters before leading.
- **Pure secondary fund:** 20-40% discount to last round. They want IRR.
- **Tender platform / broker tender:** platform-specific; often 25-35% discount with 3-7% platform fee on top.
- **Company buyback:** typically at 409A or modest premium; rarely at last-round price (cash-conservation logic).
- **HNWI / family office:** wide range, depends on relationship and conviction.

### Bid-ask realism

A "$50/share IOI" on a platform is not a price. The mid is. Cleared prices are. Ask the broker for last 4 cleared trades (they may say no — push). If the spread is more than 20%, expect to wait, lower your ask, or walk.

## Structure choices

### One-off direct transfer
Single buyer purchases directly. Cleanest legally, best price typically (no platform fee), but requires the most ROFR / board / investor coordination. Best for: $1M-$10M transactions to a known buyer.

### Company-coordinated tender (cleanest at scale)
Company runs a window — eligible holders can sell pro-rata at a fixed price to one or several pre-arranged buyers. Pros: company control, equal-treatment optics, no per-trade ROFR friction. Cons: founder might not get above-tender pricing, tender price is generally below where individual sale could clear. Best for: post-Series C/D companies with employee retention pressure.

### Broker-led tender (platform)
EquityZen, Forge, Hiive, Carta X. They aggregate sellers, find buyers, handle paperwork. Pros: liquidity for hard-to-place stock. Cons: 3-7% fee; price often below direct sale; some companies refuse to honor platform-led transfers (ROFR, non-transferable language); signaling.
- EquityZen: typically founder/early-employee focused, 5% buyer-side + 5% seller-side fee historically.
- Forge: marketplace + custodian; institutional-friendly.
- Hiive: aggressive marketplace; live order book.
- Carta X: cap-table-native; smoother on companies that use Carta.

### Forward contract / prepaid forward
Seller "agrees to sell" specific shares at IPO/exit; receives upfront cash today (typically 60-80% of current secondary value). Triangulating tax + risk + cash today.
- Pros: cash now, may preserve QSBS clock (tax-treatment depends on contract structure).
- Cons: legal complexity, if company stays private longer than expected the math gets ugly, downside if exit price is lower than expected.
- Use only with: experienced lawyer + tax advisor + clear understanding of contract treatment for QSBS / LTCG / capital-gain timing.

### Share-pledge loan
Borrow against shares (Equitybee, Esofund, Quid). Not a sale — debt collateralized by equity.
- Pros: keeps upside, no immediate tax event, immediate liquidity.
- Cons: interest cost, margin-call-style triggers if valuation drops, gives lender claim on shares.

### Company buyback
Company repurchases. Sometimes at a discount, sometimes at fair-market 409A. Cleanest legally — no ROFR friction.
- Pros: no platform fee, often fast, no signaling to outside market.
- Cons: company sets the price; rarely the highest clear available; uses balance-sheet cash.

## Approvals

The actual hard part of most secondaries is coordination, not pricing.

### Right of first refusal (ROFR)
Standard. Company has 15-30 days to match the offer; investors get a second look after that. Sequence:
1. Term sheet from buyer.
2. Notice to company. ROFR window starts.
3. Company decides: exercise, waive, decline.
4. If declined / waived → notice to investor co-sale and ROFR rights.
5. Investors decide.
6. If all waived → close transaction.

ROFR exercise can stop a sale cold. Practical: most companies waive if the buyer is a friendly investor; many exercise selectively for high-quality secondary buyers they want to bring on cap table.

### Co-sale right
Investors with co-sale rights can join the sale pro-rata to their stake. If you're selling 1000 shares and a Series A investor has 10% pro-rata, they can sell 100 shares alongside (effectively reducing your slot). Read carefully — co-sale is often pro-rata of fully-diluted, not of the seller's stake.

### Board approval
Most certificates require board approval for transfer. Practical: board will rubber-stamp small employee transfers (under 10% of holdings); will scrutinize founder transfers; will sometimes block aggressive secondary requests during sensitive periods (mid-fundraise, M&A talks).

### Transfer restriction language
Read the original stock purchase agreement and the operating stockholders' agreement. Look for:
- "No transfer without board approval and investor approval" — common
- "First-refusal-then-co-sale" — common
- "Lockup until [event]" — sometimes
- Specific founder restrictions (often more onerous)
- "Permitted transferees" carveouts (family trusts, LLCs) — useful for tax planning

### Investor approval / waiver
Some agreements require investor (typically Series-X majority) approval of any secondary above a threshold. Practical: if the secondary buyer is a current investor, this is usually frictionless; if the buyer is unknown or competitive to existing investors, this is the hard veto point.

## Tax planning

Critical and almost always under-thought-out.

### Holding period and LTCG
- Federal LTCG: shares held >12 months from acquisition date, taxed at 15-20% + NIIT 3.8% = 18.8-23.8% federal.
- STCG (held ≤12 months): ordinary rates, up to 37% federal + NIIT 3.8%.
- Watch start of holding period:
  - Restricted stock with 83(b) filed: holding period starts at grant.
  - Restricted stock without 83(b) (ordinary rates on vest): holding period starts at vest.
  - ISO exercise → sale: holding period starts at exercise date.
  - NSO exercise → sale: holding period starts at exercise date.
  - RSU vest → sale: holding period starts at vest date.
- Always confirm cost basis and acquisition date with the company / cap-table custodian before pricing the sale.

### QSBS Section 1202 exclusion
Federal exclusion of up to $10M (or 10× basis, whichever is greater) of LTCG on Qualified Small Business Stock. Requirements:
- Stock must be in a domestic C-corp at time of issuance.
- Company gross assets ≤$50M when issued.
- Stock issued directly (not bought from another shareholder; secondary purchases generally don't qualify for QSBS).
- Held ≥5 years.
- Active business test (≥80% of assets used in active business).
- Per-issuer limit: max(10× basis, $10M).

For founders / early employees who got original-issue stock and held 5+ years: this is often the difference between 23.8% federal tax and 0% federal tax on first $10M of gain. Coordinate sale to occur after 5-year mark if possible.

State QSBS treatment varies wildly: California disallows the federal exclusion (must pay full state rate); New York conforms (federal exclusion flows through); Massachusetts conforms; Texas / Washington / Florida have no state income tax (moot). Re-domiciling pre-sale is sometimes done aggressively — talk to a tax lawyer.

### AMT trap on ISO exercise
If seller exercised ISOs in a prior tax year and is now selling, check whether there was an AMT preference item from exercise. AMT credit may be partly recoverable. Don't ignore this — a forgotten AMT bill can be 20-28% of the bargain element.

### Section 1045 rollover
If holding QSBS <5 years, gains can be rolled into new QSBS within 60 days, preserving the 5-year clock. Niche but useful in repositioning.

### State of residence
Sale is taxed in seller's state of residence at time of sale. California: 13.3% top rate. New York: ~10.9%. Florida / Texas / Washington / Nevada / Tennessee / South Dakota: 0%. A move 6-12 months pre-sale is sometimes worth it for a $5M+ gain. CA aggressive on residency tests; document carefully.

## Founder-relationship math

Often more important than price.

### Signaling
- Founder selling 5-15% of holdings during a healthy growth round: usually fine, sometimes positive (founder de-risk = better-aligned long-term focus).
- Founder selling 30%+ holdings: red flag for new investors.
- Founder selling immediately before a fundraise: avoid; signals reduced confidence.
- Founder selling at flat or down-round price: deeply negative signal.

### Board / investor optics
- Tell the board *first*. Find out objections early.
- Frame as "long-planned, modest amount, life event."
- Offer to coordinate with company tender window if one is planned.
- Avoid: surprise transactions, secondary above the latest 409A by a lot, sales to competitors.

### Co-founder optics
- Equal treatment: if one founder sells, the other usually wants to too. Coordinate.
- Disproportionate sale: damages co-founder trust. Often worth bringing the other in.

### Employee optics
- Founders selling while employees are illiquid creates resentment. Best practice: combine with company-led employee tender. If no tender exists, push for one.

## Red-flag signals from buyers

- Cap-stack quirks: requests for board observer rights, MFN clauses, preference rights — secondary buyer should not be getting governance rights for a secondary.
- Side-letter requests: any side letter is a red flag.
- Aggressive carve-outs: indemnity demands beyond reps & warranties on share ownership.
- "Reps & warranties insurance for secondary": uncommon and adds 1-2% cost; usually unnecessary.
- Buyer using SPV: ask who's behind the SPV; if it's a fund-of-funds, fine; if it's a syndicate of unknowns, slow down.
- Last-minute price drop ("we found something in diligence"): leverage play. Don't capitulate without re-running price discovery.

## Workflow

Run this in 3 phases.

### Phase 1: Eligibility and prep (week 1-2)
- Pull stockholders' agreement, stock purchase agreement, option grants. Read transfer-restriction language line-by-line.
- Confirm vesting status, cost basis, holding-period start dates, 83(b) status.
- Confirm QSBS status with company CFO / counsel (5-year clock, $50M asset test at issuance).
- Estimate after-tax proceeds at multiple price points (gross sale → STCG/LTCG → state → AMT → net).
- Identify co-sale and ROFR mechanics (who, how much, what window).
- Talk to a tax advisor *before* pricing. State of residence matters.

### Phase 2: Pricing and buyer search (week 2-6)
- Triangulate price using all anchors (last round, 409A, recent trades, forward expectation).
- Identify 3-5 likely buyer types and reach out (existing investors first, then growth funds, then platforms).
- Get 2-3 firm IOIs before signaling commitment.
- Negotiate price + ROFR-waiver coordination upfront.
- Frame to the board / company: timing, amount, buyer identity.

### Phase 3: Approval and close (week 6-12)
- File ROFR notice. Wait the window.
- Coordinate co-sale waivers / participation.
- Sign purchase agreement; close with company / transfer-agent assistance.
- File appropriate tax forms (Schedule D, Form 8949; for QSBS, attach statement).
- Monitor for any post-close 409A reset (sometimes a secondary trade resets 409A for the company).

## Anti-patterns to flag explicitly

- **Selling on signaling-bad timing.** Avoid mid-fundraise sales unless coordinated with the round.
- **Selling without QSBS analysis.** Million-dollar mistake for many founders.
- **Pricing on 409A.** That's a floor, not a market.
- **Ignoring co-sale.** Assuming you can sell 1000 shares when investors take 30% pro-rata leaves you with 700.
- **Leaving cash on the table for "speed".** The 4-week wait often clears 15% more.
- **Selling all in one shot.** Consider phased sales over 12-24 months for diversification + price-averaging.
- **Buyer-set timeline.** If buyer is rushing, that's their problem; don't bypass diligence on your side (cost basis errors compound).

## Integration with other coaches

- saas-acquisition-prep-coach: full company sale, not secondary.
- pre-seed-fundraising-coach: primary capital raise, not secondary.
- equity-comp-negotiation-coach: getting the equity in the first place.
- term-sheet-negotiation-coach: primary preferred-round terms.
- accelerator-application-coach: pre-revenue program, different stage.

This skill assumes the founder/seller already has equity worth selling. Use it after primary fundraising is sorted, when liquidity becomes a near-term question rather than an "if we exit" abstraction.

_meta.json Metadata

{
  "ownerId": "kn7d5eszdfwftk153ymhdm4qhs83qsqy",
  "publishedAt": 1778196898140,
  "slug": "secondary-sale-negotiation-coach",
  "version": "1.0.0"
}